Biosearch Technologies and Seegene Finalize Oligonucleotide Supply and BHQ®, CAL Fluor® and Quasar® Licensing Agreements

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to Seegene (KOSDAQ; Korea Securities Dealers Automated Quotations).

To read the entire story, read the full press release.